P09874 (PARP1_HUMAN) Homo sapiens (Human)
Poly [ADP-ribose] polymerase 1 UniProtKBInterProSTRINGInteractive Modelling
1014 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
97 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human PARP1 deltaV687-E688 bound to UKTT5 (compound 10) and to a DNA double strand break. |
Heteromer | 100.0 | 1×YH0; 2×ZN; | |||
| Human PARP1 deltaV687-E688 bound to NAD+ analog EB-47 and to a DNA double strand break. |
Heteromer | 100.0 | 1×EDO; 1×UHB; 2×ZN; | |||
| Human PARP1 deltaV687-E688 bound to a DNA double strand break. |
Heteromer | 100.0 | 1×EDO; 2×ZN; | |||
| Structure of Human PARP-1 bound to a DNA double strand break |
Heteromer | 100 | 2×ZN; 1×EDO; | |||
| Structure of Human PARP-1 bound to a DNA double strand break in complex with (2R)-5-fluoro-2-methyl… |
Heteromer | 100.0 | 2×ZN; 1×2UR; | |||
| Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-{4-[2-(morpholi… |
Heteromer | 100.0 | 2×ZN; 1×2UT; | |||
| Structure of Human PARP-1 bound to a DNA double strand break in complex with (2Z)-2-(2,4-dihydroxyb… |
Heteromer | 100.0 | 2×ZN; 1×2US; | |||
| Structure of human PARP1 domains (Zn1, Zn3, WGR and HD) bound to a DNA double strand break. |
Heteromer | 100.0 | 2×ZN; | |||
| Structure of human PARP1 domains (Zn1, Zn3, WGR, HD) bound to a DNA double strand break. |
Heteromer | 100.0 | 4×ZN; | |||
| The complex structure of Timeless_PAB and PARP-1_catalytic domain |
Heteromer Q9UNS1; | 100.0 | 3×GOL; 1×ACT; | |||
| Crystal structure of HPF1/PARP1 complex |
Heteromer Q9NWY4; | 100.0 | 1×UNU; | |||
| Crystal structure of the human PARP-1 DNA binding domain in complex with DNA |
Heteromer | 100 | 4×ZN; | |||
| Nuc147 bound to multiple BRCTs |
Heteromer P04908; P06899; P62805; P68431; | 100 | ||||
| Nuc147 bound to single BRCT |
Heteromer P04908; P06899; P62805; P68431; | 100 | ||||
| PARP complexed with A861695 | homo-6-mer | 99.71 | 6×78P; | |||
| Crystal structure of catalytic domain of human poly(ADP-ribose) polymerase complexed with a quinoxa… | homo-4-mer | 100 | 4×CNQ; | |||
| Structure of human PARP1 catalytic domain bound to an isoindolinone inhibitor | homo-2-mer | 100.0 | 4×SO4; 3×GOL; 2×FSU; | |||
| Crystal structure-based design and disovery of a novel PARP1 antiagonist (BL-PA10) that induces apo… | homo-2-mer | 100 | 2×GOL; 6×SO4; 1×TP0; | |||
| Crystal Structure of the Third Zinc-binding domain of human PARP-1 | homo-2-mer | 100 | 2×ZN; 2×EOH; 6×GOL; | |||
| Human PARP-1 zinc finger 1 (Zn1) bound to DNA | homo-2-mer | 100 | 2×ZN; | |||
| Human PARP-1 zinc finger 1 (Zn1) bound to DNA | homo-2-mer | 100 | 2×ZN; | |||
| Crystal structure of PARP1 catalytic domain bound to AZD5305 (SARUPARIB) | monomer | 99.71 | 1×A1H63; 4×SO4; | |||
| Crystal structure of the catalytic domain of human PARP1 in complex with veliparib | monomer | 99.71 | 1×78P; 1×SO4; | |||
| Structure of the catalytic domain of PARP1 | monomer | 100 | 5×SO4; | |||
| Crystal structure of the catalytic domain of human PARP1 (apo) | monomer | 99.71 | 2×SO4; 1×DMS; | |||
| Crystal structure of PARP1 catalytic domain bound to AZD9574 | monomer | 99.71 | 1×A1H64; 1×SO4; | |||
| PARP1 catalytic domain in complex with a selective pyridine carboxamide-based inhibitor (compound 2… | monomer | 99.71 | 1×VKQ; 1×SO4; | |||
| Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor | monomer | 99.71 | 1×7U9; | |||
| PARP1 catalytic domain in complex with isoquinolone-based inhibitor (compound 16) | monomer | 99.71 | 1×VKT; 3×SO4; | |||
| PARP1 catalytic domain in complex with 8-chloroquinazolinone-based inhibitor (compound 9) | monomer | 99.71 | 1×VKW; 2×SO4; | |||
| Structure of the catalytic domain of PARP1 in complex with veliparib | monomer | 100 | 1×78P; 3×SO4; | |||
| ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×1WI; 2×SO4; | |||
| Crystal Structure of human PARP-1 CAT domain bound to inhibitor rucaparib | monomer | 99.71 | 1×RPB; 1×GOL; 3×SO4; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×7UL; | |||
| Structure of human PARP1 catalytic domain bound to a phthalazinone inhibitor | monomer | 99.71 | 1×7U3; | |||
| PARP complexed with benzo[1,4]oxazin-3-one inhibitor | monomer | 99.71 | 1×1WQ; | |||
| Crystal structure of the catalytic domain of human PARP1 in complex with olaparib | monomer | 99.71 | 1×09L; 2×SO4; | |||
| Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527 | monomer | 99.71 | 1×EZ2; 4×SO4; | |||
| PARP complexed with A968427 | monomer | 99.71 | 1×GJW; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×6WX; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×4YR; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×6WZ; | |||
| Crystal structure of PARP catalytic domain in complex with novel inhibitors | monomer | 99.71 | 1×15R; | |||
| PARP complexed with A906894 | monomer | 99.71 | 1×L3L; | |||
| PARP complexed with A861696 | monomer | 99.71 | 1×3GN; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×6X2; | |||
| Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor | monomer | 99.71 | 1×7U6; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×6WY; | |||
| Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor | monomer | 99.71 | 1×7TX; | |||
| Complex structure of PARP1 catalytic domain with pamiparib | monomer | 99.71 | 1×DS9; 1×GOL; | |||
| Crystal structure of PARP catalytic domain in complex with novel inhibitors | monomer | 99.71 | 1×15S; | |||
| Crystal structure of the catalytic domain of human PARP1 in complex with inhibitor EB-47 | monomer | 99.71 | 1×UHB; 2×SO4; | |||
| PARP complexed with A620223 | monomer | 100 | 1×AAI; | |||
| Human ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to a pyrazolopyrimidine carboxamide i… | monomer | 99.71 | 1×ERV; 3×SO4; | |||
| Human artd1 (parp1) - catalytic domain in complex with inhibitor xav939 | monomer | 99.71 | 5×SO4; 1×XAV; | |||
| Human ADP-ribosyltransferase 1 (PARP1) catalytic domain bound to Fluzoparib (SHR3162) | monomer | 99.71 | 1×25I; 6×SO4; | |||
| Crystal structure of catalytic domain of human poly(ADP-ribose) polymerase with a novel inhibitor | monomer | 100 | 1×FRM; | |||
| Crystal structure of human poly(ADP-ribose) polymerase complexed with a potent inhibitor | monomer | 100 | 1×FRQ; | |||
| Structure of the catalytic domain of PARP1 in complex with niraparib | monomer | 100.0 | 1×3JD; 4×SO4; | |||
| Structure of the catalytic domain of PARP1 in complex with olaparib | monomer | 100.0 | 1×09L; | |||
| Catalytic domain of human PARP-1 in complex with the inhibitor MC2050 | monomer | 100.0 | 4×NI; 6×EDO; 1×O3H; | |||
| Structure of the catalytic domain of PARP1 in complex with talazoparib | monomer | 100.0 | 1×2YQ; | |||
| Human artd1 (parp1) - catalytic domain in complex with inhibitor niraparib | monomer | 99.71 | 1×3JD; 1×SO4; 1×GOL; | |||
| HUMAN ARTD1 (PARP1) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TALAZOPARIB | monomer | 99.71 | 1×2YQ; | |||
| novel orally efficacious inhibitors complexed with PARP1 | monomer | 99.71 | 1×8E6; 1×SO4; | |||
| novel orally efficacious inhibitors complexed with PARP1 | monomer | 99.71 | 1×8EC; 2×SO4; | |||
| Structure of PARP1 catalytic domain bound to inhibitor BMN 673 | monomer | 100.0 | 4×SO4; 1×2YQ; 2×GOL; | |||
| novel orally efficacious inhibitors complexed with PARP1 | monomer | 99.71 | 6×SO4; 1×8E3; | |||
| Structure of human PARP1 catalytic domain bound to an isoindolinone inhibitor | monomer | 100.0 | 1×D7N; 2×SO4; | |||
| Human ARTD1 (PARP1) catalytic domain in complex with inhibitor Rucaparib | monomer | 99.71 | 2×SO4; 1×RPB; | |||
| Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor PJ34 | monomer | 99.69 | 1×P34; 1×SO4; | |||
| PARP complexed with A927929 | monomer | 99.71 | 1×A92; | |||
| Crystal Structure of human PARP-1 CAT domain bound to inhibitor UKTT15 | monomer | 99.71 | 1×L1S; 3×SO4; | |||
| Human ARTD1 (PARP1) - Catalytic domain in complex with inhibitor ME0328 | monomer | 99.71 | 1×MEW; | |||
| Crystal Structure of human PARP-1 CAT domain bound to inhibitor EB-47 | monomer | 99.71 | 1×UHB; 3×SO4; | |||
| Crystal Structure of human PARP-1 ART domain bound inhibitor UTT63 | monomer | 100 | 1×KYP; 5×SO4; 2×DMS; | |||
| Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT93 | monomer | 100 | 1×KYJ; 5×SO4; 2×DMS; | |||
| Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT57 | monomer | 100 | 1×KYY; 5×SO4; 3×DMS; | |||
| Crystal Structure of human PARP-1 ART domain bound to inhibitor UKTT-15 | monomer | 100 | 1×GLC; 2×DMS; 1×1PE; 1×L1S; 2×SO4; | |||
| Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT103 | monomer | 100 | 1×CIT; 1×DMS; 1×KYV; 2×CL; | |||
| Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT83 | monomer | 100 | 1×KYM; 1×CIT; 1×DMS; 1×CL; | |||
| Crystal structure of constitutively active PARP-1 | monomer | 100.0 | 1×1PE; 1×09L; 2×SO4; | |||
| Crystal structure of human PARP1 ART domain bound to inhibitor UKTT5 (compound 10) | monomer | 100 | 1×GLC; 1×YH0; 1×DMS; 1×PEG; | |||
| Human PARP-1 bound to NAD+ analog benzamide adenine dinucleotide (BAD) | monomer | 100 | 1×DQV; | |||
| The crystal structure of a helical domain deleted PARP1 in complex with isoindolinone based inhibit… | monomer | 99.54 | 1×VHU; | |||
| Crystal structure of human PARP1 ART domain bound to inhibitor UKTT22 (compound 14) | monomer | 100 | 1×GLC; 2×CIT; 2×DMS; 1×YVB; 2×EDO; | |||
| Crystal structure of human PARP1 ART domain bound to inhibitor UKTT10 (compound 13) | monomer | 100 | 2×DMS; 1×CIT; 1×YNQ; | |||
| 1H, 13C and 15N chemical shift assignments and solution structure for PARP-1 F1F2 domains in comple… | monomer | 100 | 2×ZN; | |||
| Solution structure of WGR domain of poly(ADP-ribose) polymerase-1 | monomer | 100 | ||||
| Domain C of human PARP-1 | monomer | 100 | 1×ZN; | |||
| Solution structure of the second Zn-finger domain of poly(ADP-ribose) polymerase-1 | monomer | 100 | 1×ZN; | |||
| Human PARP-1 zinc finger 2 | monomer | 100 | 1×ZN; | |||
| Human PARP-1 zinc finger 1 | monomer | 100 | 1×ZN; | |||
| Solution structure of BRCT domain of poly(ADP-ribose) polymerase-1 | monomer | 99.0 | ||||
| Human PARP-1 zinc finger 2 (Zn2) bound to DNA | monomer | 100 | 1×ZN; | |||
| Solution structure of the first zf-PARP domain of human Poly(ADP-ribose)polymerase-1 | monomer | 100 | 1×ZN; | |||
| Human PARP-1 zinc finger 2 (Zn2) bound to DNA | monomer | 100 | 1×ZN; | |||
6 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7s6h.1.A | monomer | 0.80 | 1×UHB; | 99.59 | ||
| 2cok.1.A | monomer | 0.76 | 98.99 | |||
| 2n8a.1.A | monomer | 0.69 | 2×ZN; | 100.00 | ||
| 2riq.1.B | monomer | 0.69 | 1×ZN; | 100.00 | ||
| 7s68.1.D | monomer | 0.66 | 1×ZN; | 74.39 | ||
| 7s6m.1.B | monomer | 0.56 | 1×DC; 2×ZN; | 94.86 | ||